{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:47:35Z","timestamp":1791654455222,"version":"4.3.4"},"reference-count":81,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Rudolf Virchow was the first person to point out the important link between immune function and cancer. He did this by noticing that leukocytes were often found in tumors. Overexpression of arginase 1 (ARG1) and inducible nitric oxide synthase (iNOS) in myeloid-derived suppressor cells (MDSCs) and tumour-associated macrophages (TAMs) depletes both intracellular and extracellular arginine. TCR signalling is slowed as a result, and the same types of cells produce reactive oxygen and nitrogen species (ROS and RNS), which aggravates the situation. Human arginase I is a double-stranded manganese metalloenzyme that helps L-arginine break down into L-ornithine and urea. Thus, a quantitative structure-activity relationship (QSAR) analysis was performed to unearth the unrecognised structural aspects crucial for arginase-I inhibition. In this work, a balanced QSAR model with good prediction performance and clear mechanistic interpretation was developed using a dataset of 149 molecules encompassing a broad range of structural scaffolds and compositions. The model was made to meet OECD standards, and all of its validation parameters have values that are higher than the minimum requirements (R<jats:sup>2<\/jats:sup><jats:sub>tr<\/jats:sub> = 0.89, Q<jats:sup>2<\/jats:sup><jats:sub>LMO<\/jats:sub> = 0.86, and R<jats:sup>2<\/jats:sup><jats:sub>ex<\/jats:sub> = 0.85). The present QSAR study linked structural factors to arginase-I inhibitory action, including the proximity of lipophilic atoms to the molecule\u2019s centre of mass (within 3A), the position of the donor to the ring nitrogen (exactly 3 bonds away), and the surface area ratio. As OAT-1746 and two others are the only arginase-I inhibitors in development at the time, we have performed a QSAR-based virtual screening with 1650 FDA compounds taken from the zinc database. In this screening, 112 potential hit compounds were found to have a PIC50 value of less than 10\u00a0nm against the arginase-I receptor. The created QSAR model\u2019s application domain was evaluated in relation to the most active hit molecules identified using QSAR-based virtual screening, utilising a training set of 149 compounds and a prediction set of 112 hit molecules. As shown in the Williams plot, the top hit molecule, ZINC000252286875, has a low leverage value of HAT i\/i h* = 0.140, placing it towards the boundary of the usable range. Furthermore, one of 112 hit molecules with a docking score of \u221210.891\u00a0kcal\/mol (<jats:sub>P<\/jats:sub>IC<jats:sub>50<\/jats:sub> = 10.023\u00a0M) was isolated from a study of arginase-I using molecular docking. Protonated ZINC000252286875-linked arginase-1 showed 2.9 RMSD, whereas non-protonated had 1.8. RMSD plots illustrate protein stability in protonated and non-protonated ZINC000252286875-bound states. Protonated-ZINC000252286875-bound proteins contain 25 Rg. The non-protonated protein-ligand combination exhibits a 25.2-Rg, indicating compactness. Protonated and non-protonated ZINC000252286875 stabilised protein targets in binding cavities posthumously. Significant root mean square fluctuations (RMSF) were seen in the arginase-1 protein at a small number of residues for a time function of 500\u00a0ns in both the protonated and unprotonated states. Protonated and non-protonated ligands interacted with proteins throughout the simulation. ZINC000252286875 bound Lys64, Asp124, Ala171, Arg222, Asp232, and Gly250. Aspartic acid residue 232 exhibited 200% ionic contact. 500-ns simulations-maintained ions. Salt bridges for ZINC000252286875 aided docking. ZINC000252286875 created six ionic bonds with Lys68, Asp117, His126, Ala171, Lys224, and Asp232 residues. Asp117, His126, and Lys224 showed 200% ionic interactions. In protonated and deprotonated states, GbindvdW, GbindLipo, and GbindCoulomb energies played crucial role. Moreover, ZINC000252286875 meets all of the ADMET standards to serve as a drug. As a result, the current analyses were successful in locating a novel and potent hit molecule that inhibits arginase-I effectively at nanomolar concentrations. The results of this investigation can be used to develop brand-new arginase I inhibitors as an alternative immune-modulating cancer therapy.<\/jats:p>","DOI":"10.3389\/fphar.2023.1129997","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T04:17:17Z","timestamp":1681791437000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["In-silico studies to recognize repurposing therapeutics toward arginase-I inhibitors as a potential onco-immunomodulators"],"prefix":"10.3389","volume":"14","author":[{"given":"Magdi E. A.","family":"Zaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami A.","family":"Al-Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamal A.","family":"Al-Mutairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Samad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arabinda","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somdatta","family":"Chaudhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravin N.","family":"Khatale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Ajmire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul D.","family":"Jawarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1136\/jclinpath-2015-203491","article-title":"The expression of arginase-1, keratin (K) 8 and K18 in combined hepatocellular-cholangiocarcinoma, subtypes with stem-cell features, intermediate-cell type","volume":"69","author":"Akiba","year":"2016","journal-title":"J. Clin. Pathology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e55146","DOI":"10.1371\/journal.pone.0055146","article-title":"Arginase II expressed in cancer-associated fibroblasts indicates tissue hypoxia and predicts poor outcome in patients with pancreatic cancer","volume":"8","author":"Alg\u00fcl","year":"2013","journal-title":"PLoS ONE"},{"key":"B3","doi-asserted-by":"publisher","first-page":"7660","DOI":"10.1200\/JCO.2005.02.0933","article-title":"Pegylated arginine deiminase treatment of patients with metastatic melanoma: Results from phase I and II studies","volume":"23","author":"Ascierto","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"8107","DOI":"10.1021\/ja971312d","article-title":"Inhibition of Mn2+2-arginase by borate leads to the design of a transition state analogue inhibitor, 2(S)-Amino-6-boronohexanoic acid","volume":"119","author":"Baggio","year":"1997","journal-title":"J. Am. Chem. Soc."},{"key":"B5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jsps.2022.04.003","article-title":"Identification of potent aldose reductase inhibitors as antidiabetic (Anti-hyperglycemic) agents using QSAR based virtual Screening, molecular Docking, MD simulation and MMGBSA approaches","volume":"30","author":"Bakal","year":"2022","journal-title":"Saudi Pharm. J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"E85","DOI":"10.1002\/ijc.27728","article-title":"Prognostic value of arginase-II expression and regulatory T-cell infiltration in head and neck squamous cell carcinoma","volume":"132","author":"Bron","year":"2013","journal-title":"Int. J. Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nri1668","article-title":"Regulation of immune responses by L-arginine metabolism","volume":"5","author":"Bronte","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/0097-8485(95)00062-3","article-title":"A protein structure comparison methodology","volume":"20","author":"Brown","year":"1996","journal-title":"Comput. Chem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"8445","DOI":"10.1021\/bi034340j","article-title":"Human arginase II: Crystal structure and physiological role in male and female sexual arousal","volume":"42","author":"Cama","year":"2003","journal-title":"Biochemistry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"8987","DOI":"10.1021\/bi0491705","article-title":"Inhibitor coordination interactions in the binuclear manganese cluster of arginase","volume":"43","author":"Cama","year":"2004","journal-title":"Biochemistry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1172\/JCI19617","article-title":"A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression","volume":"113","author":"Cerutti","year":"2004","journal-title":"J. Clin. Investigation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1021\/ci200211n","article-title":"Real external predictivity of QSAR models: How to evaluate it? Comparison of different validation criteria and proposal of using the concordance correlation coefficient","volume":"51","author":"Chirico","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1021\/ci900115y","article-title":"Comments on the definition of the Q2 parameter for QSAR validation","volume":"49","author":"Consonni","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e1800124","DOI":"10.1002\/minf.201800124","article-title":"Integrated QSAR models to predict acute oral systemic toxicity","volume":"38","author":"Consonni","year":"2019","journal-title":"Mol. Inf."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1038\/s41467-019-10979-3","article-title":"Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma","volume":"10","author":"Czystowska-Kuzmicz","year":"2019","journal-title":"Nat. Commun."},{"key":"B16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/10629360902949567","article-title":"How not to develop a quantitative structure\u2013activity or structure\u2013property relationship (QSAR\/QSPR)","volume":"20","author":"Dearden","year":"2009","journal-title":"SAR QSAR Environ. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.abb.2010.02.004","article-title":"Inhibition of human arginase I by substrate and product analogues","volume":"496","author":"Di Costanzo","year":"2010","journal-title":"Archives Biochem. Biophysics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/s0006-291x(86)80333-3","article-title":"Isolation of human liver arginase cdna and demonstration of nonhomology between the two human arginase genes","volume":"141","author":"Dizikes","year":"1986","journal-title":"Biochem. Biophysical Res. Commun."},{"key":"B19","doi-asserted-by":"publisher","first-page":"104497","DOI":"10.1016\/j.bioorg.2020.104497","article-title":"Synthesis, molecular docking, and in silico ADME\/Tox profiling studies of new 1-aryl-5-(3-azidopropyl)indol-4-ones: Potential inhibitors of SARS CoV-2 main protease","volume":"106","author":"Dom\u00ednguez-Villa","year":"2021","journal-title":"Bioorg. Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/tox.20576","article-title":"Differential toxicity of Disperse Red 1 and Disperse Red 13 in the Ames test, HepG2 cytotoxicity assay, and Daphnia acute toxicity test","volume":"26","author":"Ferraz","year":"2011","journal-title":"Environ. Toxicol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1021\/acs.jcim.5b00229","article-title":"Understanding the roles of the \u201ctwo QSARs\u201d","volume":"56","author":"Fujita","year":"2016","journal-title":"J. Chem. Inf. Model."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s00262-011-1028-0","article-title":"Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13","volume":"60","author":"Gabitass","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1093\/bioinformatics\/btv458","article-title":"NRGsuite: A PyMOL plugin to perform docking simulations in real time using FlexAID","volume":"31","author":"Gaudreault","year":"2015","journal-title":"Bioinformatics"},{"key":"B24","doi-asserted-by":"publisher","first-page":"812565","DOI":"10.3389\/fphar.2021.812565","article-title":"Target specific inhibition of protein tyrosine kinase in conjunction with cancer and SARS-COV-2 by olive nutraceuticals","volume":"12","author":"Ghosh","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3390\/bioengineering10010100","article-title":"In-silico lead druggable compounds identification against SARS COVID-19 main protease target from in-house, chembridge and zinc databases by structure-based virtual screening, molecular docking and molecular dynamics simulations","volume":"10","author":"Ghufran","year":"2023","journal-title":"Bioengineering"},{"key":"B26","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1067\/mlc.2001.114543","article-title":"Significance of arginase and ornithine in malignant tumors of the human skin","volume":"137","author":"G\u00f6kmen","year":"2001","journal-title":"J. Laboratory Clin. Med."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd002033.pub2","article-title":"Nystatin prophylaxis and treatment in severely immunodepressed patients","volume":"2017","author":"G\u00f8tzsche","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/minf.201200075","article-title":"QSAR modeling is not \u201cpush a button and find a correlation\u201d: A case study of toxicity of (Benzo-)triazoles on algae","volume":"31","author":"Gramatica","year":"2012","journal-title":"Mol. Inf."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1002\/jcc.23361","article-title":"Qsarins: A new software for the development, analysis, and validation of QSAR mlr models","volume":"34","author":"Gramatica","year":"2013","journal-title":"J. Comput. Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4018\/ijqspr.20200701.oa1","article-title":"Principles of QSAR modeling","volume":"5","author":"Gramatica","year":"2020","journal-title":"Int. J. Quantitative Structure-Property Relat."},{"key":"B31","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3389\/fimmu.2020.00938","article-title":"Myeloid cell-derived arginase in cancer immune response","volume":"11","author":"Grzywa","year":"2020","journal-title":"Front. Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3389\/fphar.2019.00434","article-title":"In silico ADME and toxicity prediction of ceftazidime and its impurities","volume":"10","author":"Han","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1073\/pnas.84.2.412","article-title":"Molecular cloning and nucleotide sequence of cDNA for human liver arginase","volume":"84","author":"Haraguchi","year":"1987","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3390\/molecules27030917","article-title":"A comprehensive in silico exploration of pharmacological properties, bioactivities, molecular docking, and anticancer potential of vieloplain F from xylopia vielana targeting B-raf kinase","volume":"27","author":"Hassan","year":"2022","journal-title":"Molecules"},{"key":"B35","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.3390\/molecules27154758","article-title":"QSAR evaluations to unravel the structural features in lysine-specific histone demethylase 1A inhibitors for novel anticancer lead development supported by molecular docking, MD simulation and MMGBSA","volume":"27","author":"Jawarkar","year":"","journal-title":"Molecules"},{"key":"B36","doi-asserted-by":"publisher","first-page":"103499","DOI":"10.1016\/j.arabjc.2021.103499","article-title":"QSAR based virtual screening derived identification of a novel hit as a sars CoV-229E 3CLpro inhibitor: GA-MLR QSAR modeling supported by molecular docking, molecular dynamics simulation and MMGBSA calculation approaches","volume":"15","author":"Jawarkar","year":"","journal-title":"Arabian J. Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0305-0491(95)02138-8","article-title":"Comparative properties of arginases","volume":"114","author":"Jenkinson","year":"1996","journal-title":"Comp. Biochem. Physiology Part B Biochem. Mol. Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"B39","doi-asserted-by":"publisher","first-page":"107322","DOI":"10.1016\/j.compbiolchem.2020.107322","article-title":"Geo-measures: A PyMOL plugin for protein structure ensembles analysis","volume":"87","author":"Kagami","year":"2020","journal-title":"Comput. Biol. Chem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11095-005-8476-1","article-title":"Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability\/bioequivalence studies","volume":"23","author":"Kalantzi","year":"2006","journal-title":"Pharm. Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/383554a0","article-title":"Structure of a unique binuclear manganese cluster in arginase","volume":"383","author":"Kanyo","year":"1996","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","first-page":"D198","DOI":"10.1093\/nar\/gkl999","article-title":"BindingDB: A web-accessible database of experimentally determined protein-ligand binding affinities","volume":"35","author":"Liu","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"152383","DOI":"10.1016\/j.prp.2019.03.012","article-title":"Overexpression of Arginase-1 is an indicator of poor prognosis in patients with colorectal cancer","volume":"215","author":"Ma","year":"2019","journal-title":"Pathol. - Res. Pract."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1021\/ci300338w","article-title":"Does rational selection of training and test sets improve the outcome of QSAR modeling?","volume":"52","author":"Martin","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1063\/1.463940","article-title":"Nos\u00e9\u2013Hoover chains: The canonical ensemble via continuous dynamics","volume":"97","author":"Martyna","year":"1992","journal-title":"J. Chem. Phys."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s00044-014-1193-8","article-title":"Effect of information leakage and method of splitting (rational and random) on external predictive ability and behavior of different statistical parameters of QSAR model","volume":"24","author":"Masand","year":"2014","journal-title":"Med. Chem. Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.chemolab.2017.08.003","article-title":"PyDescriptor: A new PyMOL plugin for calculating thousands of easily understandable molecular descriptors","volume":"169","author":"Masand","year":"2017","journal-title":"Chemom. Intelligent Laboratory Syst."},{"key":"B48","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40425-019-0504-5","article-title":"Suppression of myeloid cell arginase activity leads to therapeutic response in a NSCLC mouse model by activating anti-tumor immunity","volume":"7","author":"Miret","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"B49","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1021\/acsmedchemlett.0c00058","article-title":"Discovery and optimization of rationally designed bicyclic inhibitors of human arginase to enhance cancer immunotherapy","volume":"11","author":"Mitcheltree","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1182\/blood-2004-07-2521","article-title":"Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity","volume":"105","author":"Munder","year":"2005","journal-title":"Blood"},{"key":"B51","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ni.3323","article-title":"Amino acid auxotrophy as a system of immunological control nodes","volume":"17","author":"Murray","year":"2016","journal-title":"Nat. Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1182\/blood-2013-01-480129","article-title":"Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment","volume":"122","author":"Mussai","year":"2013","journal-title":"Blood"},{"key":"B53","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1158\/0008-5472.CAN-14-3443","article-title":"Neuroblastoma arginase activity creates an immunosuppressive microenvironment that impairs autologous and engineered immunity","volume":"75","author":"Mussai","year":"2015","journal-title":"Cancer Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/026119290503300209","article-title":"Current status of methods for defining the applicability domain of (quantitative) structure-activity relationships. The report and recommendations of ECVAM Workshop 52","volume":"33","author":"Netzeva","year":"2019","journal-title":"Altern. Laboratory Animals"},{"key":"B55","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: An open chemical toolbox","volume":"3","author":"O'boyle","year":"2011","journal-title":"J. Cheminformatics"},{"key":"B56","doi-asserted-by":"publisher","first-page":"78","DOI":"10.14740\/gr1156","article-title":"Prognostic implications of arginase and cytokeratin 19 expression in hepatocellular carcinoma after curative hepatectomy: Correlation with recurrence-free survival","volume":"12","author":"Obiorah","year":"2019","journal-title":"Gastroenterology Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/00000658-200103000-00014","article-title":"Arginase I expression and activity in human mononuclear cells after injury","volume":"233","author":"Ochoa","year":"2001","journal-title":"Ann. Surg."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.cmet.2018.04.009","article-title":"Arginase 2 suppresses renal carcinoma progression via biosynthetic cofactor pyridoxal phosphate depletion and increased polyamine toxicity","volume":"27","author":"Ochocki","year":"2018","journal-title":"Cell Metab."},{"key":"B59","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","article-title":"Cancer immunoediting and resistance to T cell-based immunotherapy","volume":"16","author":"O\u2019donnell","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1017\/S0033583513000024","article-title":"Protonation and pK changes in protein\u2013ligand binding","volume":"46","author":"Onufriev","year":"2013","journal-title":"Q. Rev. Biophysics"},{"key":"B61","doi-asserted-by":"publisher","first-page":"289","DOI":"10.17344\/acsi.2020.5985","article-title":"Combined 3D-QSAR and molecular docking analysis of thienopyrimidine derivatives as Staphylococcus aureus inhibitors","volume":"68","author":"Ouassaf","year":"2021","journal-title":"Acta Chim. Slov."},{"key":"B62","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"B63","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/s0009-8981(02)00391-1","article-title":"Arginase in patients with breast cancer","volume":"328","author":"Porembska","year":"2003","journal-title":"Clin. Chim. Acta"},{"key":"B64","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/med.21419","article-title":"Arginase inhibitors: A rational approach over one century","volume":"37","author":"Pudlo","year":"2017","journal-title":"Med. Res. Rev."},{"key":"B65","doi-asserted-by":"publisher","first-page":"104553","DOI":"10.1016\/j.yrtph.2019.104553","article-title":"Nonclinical evaluation of IQG-607, an anti-tuberculosis candidate with potential use in combination drug therapy","volume":"111","author":"Rodrigues-Junior","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1600-065X.2008.00608.x","article-title":"Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: Mechanisms and therapeutic perspectives","volume":"222","author":"Rodr\u00edguez","year":"2008","journal-title":"Immunol. Rev."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1021\/ct900587b","article-title":"Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field","volume":"6","author":"Shivakumar","year":"2010","journal-title":"J. Chem. Theory Comput."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1172\/JCI31422","article-title":"Altered macrophage differentiation and immune dysfunction in tumor development","volume":"117","author":"Sica","year":"2007","journal-title":"J. Clin. Investigation"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1956143","DOI":"10.1080\/2162402X.2021.1956143","article-title":"Inhibition of arginase modulates T-cell response in the tumor microenvironment of lung carcinoma","volume":"10","author":"Sosnowska","year":"2021","journal-title":"OncoImmunology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"4616","DOI":"10.1002\/ptr.7107","article-title":"Silibinin as potential tool against SARS\u2010cov\u20102: In silico spike receptor\u2010binding domain and main protease molecular docking analysis, and in vitro endothelial protective effects","volume":"35","author":"Speciale","year":"2021","journal-title":"Phytother. Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1021\/ci800420z","article-title":"Influence of protonation, tautomeric, and stereoisomeric states on Protein\u2212Ligand docking results","volume":"49","author":"Ten Brink","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"B72","doi-asserted-by":"crossref","DOI":"10.1002\/9783527628766","volume-title":"Molecular descriptors for chemoinformatics","author":"Todeschini","year":"2009"},{"key":"B73","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s10822-011-9462-9","article-title":"Open3DALIGN: An open-source software aimed at unsupervised ligand alignment","volume":"25","author":"Tosco","year":"2011","journal-title":"J. Computer-Aided Mol. Des."},{"key":"B74","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0010-4655(96)00016-1","article-title":"Ewald summation techniques in perspective: A survey","volume":"95","author":"Toukmaji","year":"1996","journal-title":"Comput. Phys. Commun."},{"key":"B75","doi-asserted-by":"publisher","first-page":"8164","DOI":"10.1021\/acs.jmedchem.9b00931","article-title":"Discovery of N-substituted 3-Amino-4-(3-boronopropyl)pyrrolidine-3-carboxylic acids as highly potent third-generation inhibitors of human arginase I and II","volume":"62","author":"Van Zandt","year":"2019","journal-title":"J. Med. Chem."},{"key":"B76","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/BF00202199","article-title":"Immunohistochemical study of arginase in cancer of the stomach","volume":"428","author":"Wu","year":"1996","journal-title":"Virchows Arch."},{"key":"B77","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3389\/fimmu.2013.00149","article-title":"Arginase: The emerging therapeutic target for vascular oxidative stress and inflammation","volume":"4","author":"Yang","year":"2013","journal-title":"Front. Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/ijc.22322","article-title":"Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivationviaarginine deiminase","volume":"120","author":"Yoon","year":"2007","journal-title":"Int. J. Cancer"},{"key":"B79","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1086\/508200","article-title":"Decreased expression of CD3zeta and nuclear transcription factor kappa B in patients with pulmonary tuberculosis: Potential mechanisms and reversibility with treatment","volume":"194","author":"Zea","year":"2006","journal-title":"J. Infect. Dis."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1172\/JCI17912","article-title":"Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis","volume":"111","author":"Zimmermann","year":"2003","journal-title":"J. Clin. Investigation"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1129997\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T04:17:22Z","timestamp":1681791442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1129997\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,18]]},"references-count":81,"alternative-id":["10.3389\/fphar.2023.1129997"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1129997","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,18]]},"article-number":"1129997"}}